Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06828185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Study acronym: PRESERVE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 2026 to Dec 2026v7
  2. Start date: Dec 2025 to May 2026v6
  3. Start date: Sep 2025 to Dec 2025v5
  4. Start date: May 2025 to Sep 2025v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  6. Start date: Apr 1, 2025 to May 2025v2 Show 6 more changesShow less
    • Primary endpoint revised
    • Primary completion date: Jul 30, 2028 to Sep 2028
    • Study completion date: Jul 30, 2029 to Sep 2029
    • Secondary endpoints: 5 to 2
    • Site contact updated
    • Study title shortened, about 4 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchiectomy) for treatment of patients with suspected testicular malignancy. The main questions it aims to answer are: 1. Does sparing the external oblique fascia during orchiectomy reduce pain after surgery? 2. Is there a difference in narcotic consumption after surgery? 3. Is there a difference in neuropathic pain after surgery? 4. Is there a difference in complications after surgery?
Trial Details
NCT Number NCT06828185
Lead Sponsor Loma Linda University
Conditions
(from sponsor)		 Testicular Cancer
Related terms Neoplasms, Germ Cell and Embryonal, Postoperative Pain, Testicular Neoplasms
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov